Literature DB >> 15869811

The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV).

Vicente Micol1, Nuria Caturla, Laura Pérez-Fons, Vicente Más, Luis Pérez, Amparo Estepa.   

Abstract

A commercial plant extract derived from olive tree leaf (Olea europaea) (LExt) and its major compound, oleuropein (Ole), inhibited the in vitro infectivity of the viral haemorrhagic septicaemia virus (VHSV), a salmonid rhabdovirus. Incubation of virus with LExt or Ole before infection reduced the viral infectivity to 10 and 30%, respectively. Furthermore, LExt drastically decreased VHSV titers and viral protein accumulation (virucidal effect) in a dose dependent manner when added to cell monolayers 36 h post-infection. On the other hand, both the LExt and Ole were able to inhibit cell-to-cell membrane fusion induced by VHSV in uninfected cells, suggesting interactions with viral envelope. Therefore, we propose that O. europaea could be used as a potential source of promising natural antivirals, which have demonstrated to lack impact on health and environment. In addition, Ole could be used to design other related antiviral agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15869811     DOI: 10.1016/j.antiviral.2005.02.005

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  26 in total

1.  Olea europaea leaf extract alters microRNA expression in human glioblastoma cells.

Authors:  Berrin Tunca; Gulcin Tezcan; Gulsah Cecener; Unal Egeli; Secil Ak; Hulusi Malyer; Gulendam Tumen; Ayhan Bilir
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-22       Impact factor: 4.553

2.  The antioxidant and anti-proliferative activity of the Lebanese Olea europaea extract.

Authors:  Rida Fares; Samer Bazzi; Serine E Baydoun; Roula M Abdel-Massih
Journal:  Plant Foods Hum Nutr       Date:  2011-03       Impact factor: 3.921

3.  Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease.

Authors:  Sinan Bilginer; Sefa Gözcü; Zuhal Güvenalp
Journal:  Turk J Pharm Sci       Date:  2022-08-31

Review 4.  Review of Medicinal Plants and Active Pharmaceutical Ingredients against Aquatic Pathogenic Viruses.

Authors:  Wenyu Liao; Lin Huang; Shuyu Han; Dasheng Hu; Youhou Xu; Mingzhu Liu; Qing Yu; Shuaishuai Huang; Dongdong Wei; Pengfei Li
Journal:  Viruses       Date:  2022-06-13       Impact factor: 5.818

5.  Oleuropein in olive and its pharmacological effects.

Authors:  Syed Haris Omar
Journal:  Sci Pharm       Date:  2010-04-23

Review 6.  Traditional Uses, Phytochemistry, and Pharmacology of Olea europaea (Olive).

Authors:  Muhammad Ali Hashmi; Afsar Khan; Muhammad Hanif; Umar Farooq; Shagufta Perveen
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-23       Impact factor: 2.629

Review 7.  Effects of the olive-derived polyphenol oleuropein on human health.

Authors:  Barbara Barbaro; Gabriele Toietta; Roberta Maggio; Mario Arciello; Mirko Tarocchi; Andrea Galli; Clara Balsano
Journal:  Int J Mol Sci       Date:  2014-10-14       Impact factor: 5.923

8.  Phytochemical Characterization of Olea europea Leaf Extracts and Assessment of Their Anti-Microbial and Anti-HSV-1 Activity.

Authors:  Ichrak Ben-Amor; Maria Musarra-Pizzo; Antonella Smeriglio; Manuela D'Arrigo; Rosamaria Pennisi; Hammadi Attia; Bochra Gargouri; Domenico Trombetta; Giuseppina Mandalari; Maria Teresa Sciortino
Journal:  Viruses       Date:  2021-06-07       Impact factor: 5.048

9.  An evaluation of the inhibitory effects against rotavirus infection of edible plant extracts.

Authors:  Karen Knipping; Johan Garssen; Belinda van't Land
Journal:  Virol J       Date:  2012-07-26       Impact factor: 4.099

10.  Olive (Olea europaea) leaf extract induces apoptosis and monocyte/macrophage differentiation in human chronic myelogenous leukemia K562 cells: insight into the underlying mechanism.

Authors:  Imen Samet; Junkyu Han; Lobna Jlaiel; Sami Sayadi; Hiroko Isoda
Journal:  Oxid Med Cell Longev       Date:  2014-04-06       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.